These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer. Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692 [TBL] [Abstract][Full Text] [Related]
24. Genetic alterations in prostate cancer. Isaacs WB; Bova GS; Morton RA; Bussemakers MJ; Brooks JD; Ewing CM Cold Spring Harb Symp Quant Biol; 1994; 59():653-9. PubMed ID: 7587126 [TBL] [Abstract][Full Text] [Related]
25. Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer. Padalecki SS; Troyer DA; Hansen MF; Saric T; Schneider BG; O'Connell P; Leach RJ Int J Cancer; 2000 Mar; 85(5):654-8. PubMed ID: 10699945 [TBL] [Abstract][Full Text] [Related]
26. Genetic changes associated with prostate cancer in humans. Isaacs WB; Carter BS Cancer Surv; 1991; 11():15-24. PubMed ID: 1841750 [TBL] [Abstract][Full Text] [Related]
27. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Bova GS; MacGrogan D; Levy A; Pin SS; Bookstein R; Isaacs WB Genomics; 1996 Jul; 35(1):46-54. PubMed ID: 8661103 [TBL] [Abstract][Full Text] [Related]
28. Chromosome 16 in primary prostate cancer: a microsatellite analysis. Osman I; Scher H; Dalbagni G; Reuter V; Zhang ZF; Cordon-Cardo C Int J Cancer; 1997 May; 71(4):580-4. PubMed ID: 9178811 [TBL] [Abstract][Full Text] [Related]
29. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. MacGrogan D; Levy A; Bova GS; Isaacs WB; Bookstein R Genomics; 1996 Jul; 35(1):55-65. PubMed ID: 8661104 [TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102 [TBL] [Abstract][Full Text] [Related]
31. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8. Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003 [TBL] [Abstract][Full Text] [Related]
32. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Gao X; Porter AT; Honn KV Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930 [TBL] [Abstract][Full Text] [Related]
33. Yeast artificial chromosome and radiation hybrid map of loci in chromosome band 8p22, a common region of allelic loss in multiple human cancers. Bookstein R; Levy A; MacGrogan D; Lewis TB; Weissenbach J; O'Connell P; Leach RJ Genomics; 1994 Nov; 24(2):317-23. PubMed ID: 7698754 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of proximal 6q deletions in prostate cancer. Cooney KA; Wetzel JC; Consolino CM; Wojno KJ Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584 [TBL] [Abstract][Full Text] [Related]
35. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer. Massenkeil G; Oberhuber H; Hailemariam S; Sulser T; Diener PA; Bannwart F; Schäfer R; Schwarte-Waldhoff I Anticancer Res; 1994; 14(6B):2785-90. PubMed ID: 7872719 [TBL] [Abstract][Full Text] [Related]
36. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site. Prasad MA; Trybus TM; Wojno KJ; Macoska JA Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507 [TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446 [TBL] [Abstract][Full Text] [Related]
38. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714 [TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer. Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864 [TBL] [Abstract][Full Text] [Related]
40. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]